Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 30-day, Randomized, Open-Label, Multicenter Study Exploring Efficacy of Intensive Rosuvastatin Treatment Peri-PCI in Chinese Patients With NSTE-ACS

NCT02284503 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.

NCT NCT02284503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02284503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 30-day, Randomized, Open-Label, Multicenter Study Exploring Efficacy of Intensive Rosuvastatin Treatment Peri-PCI in Chinese Patients With NSTE-ACS
Lead sponsor
Shanghai Zhongshan Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2014
Completion date
June 30, 2016
Enrollment
1,350 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-st-elevation acute coronary syndromes